Simcere Pharmaceutical Group. Earnings: What Investors Should Watch
Simcere Pharmaceutical Group. (NYSE:SCR) will report earnings before markets open on Thursday, May 9th. Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company’s products include antibiotics, anti-cancer medications and anti-stroke medications.
Here is your Cheat Sheet to Simcere Pharmaceutical Group. Earnings:
Earnings Expectations: Analysts expect earnings of $0.08 per share on revenues of $82.83 million. Currently, the company’s P/E ratio stands at 53.79.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.11 to a profit $0.12. For the current year, the average estimate is a profit of $0.39, which is better than the estimate ninety days ago.
Here’s how Simcere Pharmaceutical Group. has been performing on an annual basis:
|Revenue ($) in millions||255.55||272.41||323.80||323.43||333.82|
|Diluted EPS ($)||0.8219||0.0675||0.4688||0.5104||0.1699|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||81.00||77.32||83.17||83.54||86.56|
|Diluted EPS ($)||0.1147||0.0825||0.0786||0.0666||-0.0634|
Simcere Pharmaceutical Group. has beat analyst estimates 1 time in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)